Myeloma

• Health & Medicine
• Science & Technology

NICE recommends elranatamab for adults with a rare form of blood cancer

The National Institute for Health and Care Excellence (NICE) has recommended the use of elranatamab for adults with multiple myeloma, a cancer that forms in a type of white blood cell called a plasma cell. The National Institute for Health and Care Excellence (NICE) has recommended the use of elranatamab for adults with multiple myeloma, a cancer that forms in a type of white blood cell called a plasma cell.

1 November 2024

• For Researchers

Getting precise over multiple myeloma

Lessons must be learnt from the personalised medicine revolution in solid cancers if we are to push treatment of multiple myeloma forward Lessons must be learnt from the personalised medicine revolution in solid cancers if we are to push treatment of multiple myeloma forward

8 January 2024

• For Researchers

The path to prevention is paved with biological insight

Our first two Biology-Prevention awardees take us through their exciting work, and tell us why they think a biological approach to cancer prevention is so important… Our first two Biology-Prevention awardees take us through their exciting work, and tell us why they think a biological approach to cancer prevention is so important…

30 October 2023

• Health & Medicine

New tool to tackle gaps in public’s knowledge of blood cancer symptoms

Researchers have developed the Blood CAM tool which could shape future blood cancer awareness campaigns and save lives. Researchers have developed the Blood CAM tool which could shape future blood cancer awareness campaigns and save lives.

14 July 2023

• Science & Technology

Stressed out – the cancer cells that survive chemotherapy, but at a cost

A group of Cancer Research UK-funded scientists are beginning to discover new vulnerabilities in cancer cells, which emerge when they enter ‘survival mode’. A group of Cancer Research UK-funded scientists are beginning to discover new vulnerabilities in cancer cells, which emerge when they enter ‘survival mode’.

29 April 2021

• Health & Medicine

Three new cancer drugs approved for NHS in Scotland

The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma. The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma.

21 January 2021

• Health & Medicine

Myeloma maintenance treatment not recommended on NHS in England

Cancer drug lenalidomide receives an initial rejection to treat some adults with myeloma following a stem cell transplant. Cancer drug lenalidomide receives an initial rejection to treat some adults with myeloma following a stem cell transplant.

10 September 2020

• Health & Medicine

Three new cancer treatments available for NHS patients in Scotland

A breast cancer drug and two blood cancer treatments have been recommended for use on the NHS in Scotland. A breast cancer drug and two blood cancer treatments have been recommended for use on the NHS in Scotland.

11 July 2019

• Health & Medicine

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment. A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment.

17 May 2019

• Health & Medicine

‘Game-changing’ myeloma drug combo approved for NHS use in England

A new treatment for people with multiple myeloma will now be available on the NHS in England. A new treatment for people with multiple myeloma will now be available on the NHS in England.

12 March 2019

• Health & Medicine

NICE given grant to research patient preference

NICE will undertake a methodological study into patient health preferences after receiving a £120,000 grant courtesy of Myeloma UK. NICE will undertake a methodological study into patient health preferences after receiving a £120,000 grant courtesy of Myeloma UK.

2 June 2016

• Science & Technology
• Health & Medicine

Virtual reality and precision diagnosis among shortlist for our Grand Challenge

Find out the details of the nine ideas that could answer one of our Grand Challenges in cancer prevention, diagnosis and treatment. Find out the details of the nine ideas that could answer one of our Grand Challenges in cancer prevention, diagnosis and treatment.

14 April 2016